This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q64646381
rdf:type
wikibase:Item
schema:description
clinical trial klinisch onderzoek клінічне випробування ensayu clínicu
rdfs:label
Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia
skos:prefLabel
Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia
schema:name
Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia
p:P1476
wds:Q64646381-E7A92CD8-7171-4DED-A829-10C6E8F71FAA
wdt:P1476
A Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study to Assess Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia
p:P582
wds:Q64646381-C4B01CBA-333D-43B6-A621-CEA41FB74F97
wdt:P582
2013-11-01T00:00:00Z
p:P31
wds:Q64646381-823235CD-917A-4EE2-8E47-942FF02499D4
wdt:P31
wd:Q30612
p:P580
wds:Q64646381-CF117B37-EB52-415A-B3FC-ACC6BA42346E
wdt:P580
2011-12-01T00:00:00Z
p:P17
wds:Q64646381-25A65AF6-01E9-4052-8EE4-9568F1FC8F19 wds:Q64646381-A3736267-7CD5-493E-906A-FC4A27729995 wds:Q64646381-47E49F13-FBB9-4BA3-B141-4E6A2B389EA9 wds:Q64646381-004F2461-290B-4A70-AC0F-5AFE4157AF14 wds:Q64646381-A7DE91BF-D3A4-489D-A553-A424F7CC40DA
wdt:P17
wd:Q28 wd:Q218 wd:Q30 wd:Q212 wd:Q403
p:P6153
wds:Q64646381-16E8DD69-A50B-4CBF-B929-50A68D085A47 wds:Q64646381-D86A0BB0-5980-4AAD-AE0B-F6E03F3A311D wds:Q64646381-B1C8970F-BE17-40EC-9F05-8DBAD3C762DF wds:Q64646381-E4C36D35-D21F-4EFB-A122-0300708CC9A2
wdt:P6153
wd:Q3350649 wd:Q4304012 wd:Q30269522 wd:Q30269718
p:P2899
wds:Q64646381-B2C361E5-9BC5-46B9-AE58-DFC228443522
wdt:P2899
18
p:P1050
wds:Q64646381-B17E66DC-599F-4306-A2AC-A7D6BBCD69B4 wds:Q64646381-528AC528-83B0-44B9-8146-13C4B14D9AE2
wdt:P1050
wd:Q41112 wd:Q57859955
p:P1132
wds:Q64646381-FFE5DC6E-9E93-4708-BD33-EC7FC7F1AC96
wdt:P1132
603
p:P4135
wds:Q64646381-07A298BC-1491-47CB-8A1B-81EE1E7A2CA2
wdt:P4135
65
p:P8363
wds:Q64646381-36522180-AE11-4B1D-82CA-C08DEEB339DD
wdt:P8363
wd:Q78089383
p:P3098
wds:Q64646381-DA949F22-A57E-4F45-9555-52D3302222F1
wdt:P3098
NCT01488929
p:P6099
wds:Q64646381-C7108709-74F8-424A-9269-5234D9A7CD53
wdt:P6099
wd:Q42824440